143 related articles for article (PubMed ID: 26242143)
1. [CURRENT STATE OF ADJUVANT TREATMENT FOR GASTRIC CANCER AFTER RADICAL SURGERY WITH EXTENDED LYMPH NODE DISSECTION].
Skoropad VY
Vopr Onkol; 2015; 61(3):339-45. PubMed ID: 26242143
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study.
Kim IH; Park SS; Lee CM; Kim MC; Kwon IK; Min JS; Kim HI; Lee HH; Lee SI; Chae H
Ann Surg Oncol; 2018 May; 25(5):1176-1183. PubMed ID: 29450755
[TBL] [Abstract][Full Text] [Related]
3. New advances in the treatment of gastric cancer.
Ilson DH
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-29-33. PubMed ID: 23570096
[No Abstract] [Full Text] [Related]
4. [A case of mediastinal lymph node gastric cancer recurrence during S-1 adjuvant therapy successfully treated with cisplatin + capecitabine as second-line chemotherapy].
Hirata A; Itatsu K; Fukaya M; Ebata T; Yokoyama Y; Tsunoda N; Igami T; Sugawara G; Uehara K; Yoshioka Y; Usui H; Nagino M
Gan To Kagaku Ryoho; 2013 Apr; 40(4):519-22. PubMed ID: 23848024
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis.
He Q; Ma L; Li Y; Li G
BMC Gastroenterol; 2016 Jan; 16():8. PubMed ID: 26782354
[TBL] [Abstract][Full Text] [Related]
6. [The choice of treatment in advanced gastric cancer].
Pozzo C; Mansueto G
Tumori; 2007; 93(6):suppl 11-21. PubMed ID: 18338512
[No Abstract] [Full Text] [Related]
7. Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective, Single-Center Observational Study.
Oh SE; An JY; Choi MG; Lee JH; Sohn TS; Bae JM
Technol Cancer Res Treat; 2021; 20():15330338211039679. PubMed ID: 34605706
[No Abstract] [Full Text] [Related]
8. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
[TBL] [Abstract][Full Text] [Related]
9. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
[TBL] [Abstract][Full Text] [Related]
10. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Chemotherapy Versus Chemoradiotherapy Versus Surgery Alone for Early Gastric Cancer with One or Two Lymph Node Metastasis.
Kim SM; An JY; Lee J; Sohn TS; Kim S
Ann Surg Oncol; 2018 Jun; 25(6):1616-1624. PubMed ID: 29569127
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of adjuvant treatments for resected gastric cancer: a network meta-analysis.
Cai Z; Yin Y; Yin Y; Shen C; Wang J; Yin X; Chen Z; Zhou Y; Zhang B
Gastric Cancer; 2018 Nov; 21(6):1031-1040. PubMed ID: 29728791
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy.
Wu B; Li T; Cai J; Xu Y; Zhao G
BMC Cancer; 2014 Dec; 14():984. PubMed ID: 25526802
[TBL] [Abstract][Full Text] [Related]
16. [A case of recurrent gastric cancer during adjuvant chemotherapy with S-1, treated by S-1 combination chemotherapy].
Shibata N; Eto TA; Asada T; Takaya T; Tanaka S; Shimayama T; Imada S; Futami S; Hidaka H; Chijiiwa K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1745-8. PubMed ID: 19838040
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant treatment for esophagogastric junction cancer].
Kurokawa Y; Takiguchi S; Miyazaki Y; Takahashi T; Yamasaki M; Miyata H; Nakajima K; Mori M; Doki Y
Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):50-4. PubMed ID: 25842814
[TBL] [Abstract][Full Text] [Related]
18. [A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy].
Mihara K; Yamashiro N; Nishiya S; Kemmochi T; Ito Y; Egawa T; Nagashima A
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2358-60. PubMed ID: 25731522
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of recurrence in patients with gastric cancer after radical gastrectomy and adjuvant chemotherapy].
Du C; Guo C; Xu Q; Wang J; Zhou A
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):622-7. PubMed ID: 26714605
[TBL] [Abstract][Full Text] [Related]
20. [A clinical case of lymph node recurrence after resection of gastric cancer successfully treated by combination chemotherapy with irinotecan and cisplatin].
Fukunaga H; Endo W; Fujie Y; Shimizu K; Toyoda Y; Yoshioka A; Yoshioka S; Hojou S; Ota H; Maeura Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2418-20. PubMed ID: 21224592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
